Skip to main content
. 2021 Nov 30;11:740212. doi: 10.3389/fonc.2021.740212

Table 4.

Relationship between the budding and overall survival in different models.

Variable Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
TB location
 No 1.0 1.0 1.0
 PTB 2.37 (1.08–5.19) 0.03 2.30 (1.02–5.18) 0.04 2.39 (1.05–5.44) 0.04
 ITB 1.57 (0.69–3.60) 0.28 1.41 (0.61–3.23) 0.42 1.28 (0.55–2.96) 0.57
 TTB 2.02 (1.25–3.28) 0.004 1.92 (1.17–3.15) 0.01 1.78 (1.09–2.92) 0.02
PTB count 1.03 (1.01–1.05) 0.014 1.03 (1.01–1.05) 0.009 1.02 (1.00–1.05) 0.03
ITB count 1.03 (1.01–1.05) 0.008 1.03 (1.01–1.05) 0.010 1.02 (1.00–1.04) 0.06
TTB count 1.02 (1.01–1.03) 0.005 1.02 (1.01–1.03) 0.005 1.01 (1.00–1.02) 0.03
TB score 2.71 (1.48–4.96) 0.001 2.64 (1.40–4.95) 0.003 2.35 (1.27–4.33) 0.006
TB score
 TB score-low group 1.0 1.0 1.0
 TB score-high group 2.28 (1.46–3.54) 0.0002 2.15 (1.37–3.38) 0.0009 2.06 (1.32–3.22) 0.0015

Model 1: adjusted for other covariates; model 2: adjusted for age, sex, and body mass index; model 3: further adjusted for location, T category, N category, and peripancreatic fat infiltration.

HR, hazard ratio; CI, confidence interval; TB, tumor budding; PTB, peritumoral budding; ITB, intratumoral budding; TTB, total tumor budding (PTB+ITB).